LICRX
Price
$15.96
Change
-$0.06 (-0.37%)
Updated
May 8 closing price
Net Assets
372.76M
VTPSX
Price
$138.75
Change
-$0.54 (-0.39%)
Updated
May 8 closing price
Net Assets
469.79B
Ad is loading...

LICRX vs VTPSX

Header iconLICRX vs VTPSX Comparison
Open Charts LICRX vs VTPSXBanner chart's image
Lord Abbett International Equity R3
Price$15.96
Change-$0.06 (-0.37%)
VolumeN/A
Net Assets372.76M
Vanguard Total Intl Stock Idx InstlPls
Price$138.75
Change-$0.54 (-0.39%)
VolumeN/A
Net Assets469.79B
LICRX vs VTPSX Comparison Chart
Loading...
View a ticker or compare two or three
VS
LICRX vs. VTPSX commentary
May 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LICRX is a Buy and VTPSX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
VTPSX has more cash in the bank: 470B vs. LICRX (373M). VTPSX pays higher dividends than LICRX: VTPSX (3.05) vs LICRX (1.07). LICRX was incepted earlier than VTPSX: LICRX (18 years) vs VTPSX (14 years). LICRX (1.22) is less costly to investors than VTPSX (0.05). LICRX is a more actively managed with annual turnover of: 89.00 vs. VTPSX (3.00). LICRX has a lower initial minimum investment than VTPSX: LICRX (0) vs VTPSX (100000000). LICRX annual gain was more profitable for investors over the last year : 8.97 vs. VTPSX (8.00). VTPSX (48.79) and LICRX (46.67) have equivalent 5 years return.
LICRXVTPSXLICRX / VTPSX
Total Expense Ratio1.220.052,440%
Annual Report Gross Expense Ratio1.220.052,440%
Fund Existence18 years14 years-
Gain YTD13.29610.021133%
Front LoadN/AN/A-
Min. Initial Investment0100000000-
Min. Initial Investment IRAN/AN/A-
Net Assets373M470B0%
Annual Yield % from dividends1.073.0535%
Returns for 1 year8.978.00112%
Returns for 3 years34.7525.86134%
Returns for 5 years46.6748.7996%
Returns for 10 years30.0232.9291%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
LMGYX29.76N/A
N/A
Lord Abbett Growth Opportunities I
SAMVX11.16N/A
N/A
Virtus Ceredex Mid-Cap Value Equity A
BHCUX17.90N/A
N/A
Baron Health Care R6
VSRAX21.12N/A
N/A
Invesco Small Cap Value R
FERAX11.11N/A
N/A
First Eagle Global Real Assets A